Literature DB >> 23930198

Small molecules aimed at type III secretion systems to inhibit bacterial virulence.

Lun K Tsou1, Paul D Dossa, Howard C Hang.   

Abstract

Entities:  

Year:  2013        PMID： 23930198      PMCID： PMC3733274          DOI： 10.1039/C2MD20213A

Source DB:  PubMed          Journal:  Medchemcomm        ISSN： 2040-2503            Impact factor:   3.597


× No keyword cloud information.
  69 in total

1.  Structural insights into the assembly of the type III secretion needle complex.

Authors:  Thomas C Marlovits; Tomoko Kubori; Anand Sukhan; Dennis R Thomas; Jorge E Galán; Vinzenz M Unger
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

2.  Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle.

Authors:  Leslie Bailey; Asa Gylfe; Charlotta Sundin; Sandra Muschiol; Mikael Elofsson; Peter Nordström; Birgitta Henriques-Normark; Raimond Lugert; Anders Waldenström; Hans Wolf-Watz; Sven Bergström
Journal:  FEBS Lett       Date:  2007-01-17       Impact factor: 4.124

3.  A photoactivatable push-pull fluorophore for single-molecule imaging in live cells.

Authors:  Samuel J Lord; Nicholas R Conley; Hsiao-lu D Lee; Reichel Samuel; Na Liu; Robert J Twieg; W E Moerner
Journal:  J Am Chem Soc       Date:  2008-06-24       Impact factor: 15.419

4.  Quantification of real-time Salmonella effector type III secretion kinetics reveals differential secretion rates for SopE2 and SptP.

Authors:  Schuyler B Van Engelenburg; Amy E Palmer
Journal:  Chem Biol       Date:  2008-06

Review 5.  Salmonella interactions with host cells: type III secretion at work.

Authors:  J E Galán
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

6.  A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium.

Authors:  Kyota Kimura; Masato Iwatsuki; Takeshi Nagai; Atsuko Matsumoto; Yoko Takahashi; Kazuro Shiomi; Satoshi Omura; Akio Abe
Journal:  J Antibiot (Tokyo)       Date:  2010-12-08       Impact factor: 2.649

7.  Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia.

Authors:  Roger G Linington; Marilyn Robertson; Annick Gauthier; B Brett Finlay; Rob van Soest; Raymond J Andersen
Journal:  Org Lett       Date:  2002-11-14       Impact factor: 6.005

8.  High-throughput screen for novel antimicrobials using a whole animal infection model.

Authors:  Terence I Moy; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Ralph Mazitschek; Gabriele Casadei; Kim Lewis; Anne E Carpenter; Frederick M Ausubel
Journal:  ACS Chem Biol       Date:  2009-07-17       Impact factor: 5.100

Review 9.  DCDHF fluorophores for single-molecule imaging in cells.

Authors:  Samuel J Lord; Nicholas R Conley; Hsiao-Lu D Lee; Stefanie Y Nishimura; Andrea K Pomerantz; Katherine A Willets; Zhikuan Lu; Hui Wang; Na Liu; Reichel Samuel; Ryan Weber; Alexander Semyonov; Meng He; Robert J Twieg; W E Moerner
Journal:  Chemphyschem       Date:  2009-01-12       Impact factor: 3.102

10.  Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells.

Authors:  Sandra Muschiol; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  BMC Microbiol       Date:  2009-04-21       Impact factor: 3.605
View more
  5 in total

1.  Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.

Authors:  Lun K Tsou; Jacob S Yount; Howard C Hang
Journal:  Bioorg Med Chem       Date:  2017-03-10       Impact factor: 3.641

Review 2.  Considerations and caveats in anti-virulence drug development.

Authors:  Damien Maura; Alicia E Ballok; Laurence G Rahme
Journal:  Curr Opin Microbiol       Date:  2016-06-16       Impact factor: 7.934

3.  Inhibition of autotransporter biogenesis by small molecules.

Authors:  Maurice Steenhuis; Abdallah M Abdallah; Sabrina M de Munnik; Sebastiaan Kuhne; Geert-Jan Sterk; Bart van den Berg van Saparoea; Sibel Westerhausen; Samuel Wagner; Nicole N van der Wel; Maikel Wijtmans; Peter van Ulsen; Wouter S P Jong; Joen Luirink
Journal:  Mol Microbiol       Date:  2019-05-03       Impact factor: 3.501

4.  The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.

Authors:  Caroline E Zetterström; Jenny Hasselgren; Olli Salin; Rohan A Davis; Ronald J Quinn; Charlotta Sundin; Mikael Elofsson
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

5.  Global Analysis of Type Three Secretion System and Quorum Sensing Inhibition of Pseudomonas savastanoi by Polyphenols Extracts from Vegetable Residues.

Authors:  Carola Biancalani; Matteo Cerboneschi; Francesco Tadini-Buoninsegni; Margherita Campo; Arianna Scardigli; Annalisa Romani; Stefania Tegli
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.